Alice Fong

957 total citations · 1 hit paper
14 papers, 707 citations indexed

About

Alice Fong is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Alice Fong has authored 14 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Surgery. Recurrent topics in Alice Fong's work include IL-33, ST2, and ILC Pathways (5 papers), Obesity, Physical Activity, Diet (4 papers) and Eosinophilic Esophagitis (3 papers). Alice Fong is often cited by papers focused on IL-33, ST2, and ILC Pathways (5 papers), Obesity, Physical Activity, Diet (4 papers) and Eosinophilic Esophagitis (3 papers). Alice Fong collaborates with scholars based in United States, United Kingdom and France. Alice Fong's co-authors include Mary J. Kretsch, Michael W. Green, Daniel Wynn, Jacob Elkins, Gilmore O’Neill, Jack H. Simon, Lauri Neyer, Xavier Montalbán, James P. Sheridan and Timothy R. Vollmer and has published in prestigious journals such as New England Journal of Medicine, The Lancet Neurology and Free Radical Biology and Medicine.

In The Last Decade

Alice Fong

12 papers receiving 666 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial

2021 195 citations Steven G. Kelsen, Ioana Agache et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alice Fong United States	8	258	221	168	132	85	14	707
Hiroyasu Mori Japan	12	138 0.5×	323 1.5×	152 0.9×	61 0.5×	119 1.4×	37	638
Zbigniew Bartoszewicz Poland	15	54 0.2×	173 0.8×	97 0.6×	53 0.4×	28 0.3×	46	615
Delia Colombo Italy	11	231 0.9×	74 0.3×	159 0.9×	50 0.4×	20 0.2×	23	566
G Baviera Italy	16	135 0.5×	35 0.2×	105 0.6×	79 0.6×	49 0.6×	29	870
Zenon Brzoza Poland	19	207 0.8×	264 1.2×	277 1.6×	26 0.2×	31 0.4×	73	1.1k
Marjan Luinge Netherlands	13	351 1.4×	486 2.2×	71 0.4×	35 0.3×	77 0.9×	15	964
Alisa D. Kjærgaard Denmark	16	77 0.3×	50 0.2×	45 0.3×	71 0.5×	52 0.6×	34	676
Alan B. Goldsobel United States	12	60 0.2×	204 0.9×	48 0.3×	26 0.2×	27 0.3×	47	730
Nisha Nigil Haroon Canada	11	146 0.6×	85 0.4×	81 0.5×	25 0.2×	41 0.5×	18	657
Luca Maria Schonäuer Italy	19	121 0.5×	97 0.4×	30 0.2×	420 3.2×	22 0.3×	44	977

Countries citing papers authored by Alice Fong

Since Specialization

Citations

This map shows the geographic impact of Alice Fong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Fong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Fong more than expected).

Fields of papers citing papers by Alice Fong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Fong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Fong. The network helps show where Alice Fong may publish in the future.

Co-authorship network of co-authors of Alice Fong

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Fong. A scholar is included among the top collaborators of Alice Fong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Fong. Alice Fong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zhang, Wenhui, Dorothy Cheung, Alice Fong, et al.. (2025). Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti‐ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies. Clinical and Translational Science. 18(10). e70338–e70338.

Kelsen, Steven G., Marcus Maurer, Michael R. Waters, et al.. (2025). Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Respiratory Research. 26(1). 302–302.

Zhang, Wenhui, Dorothy Cheung, Alice Fong, et al.. (2024). Pharmacokinetics (PK) of the anti-ST2 monoclonal antibody, astegolimab. PA2987–PA2987. 2 indexed citations

Kelsen, Steven G., Ioana Agache, Weily Soong, et al.. (2021). Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. 148(3). 790–798. 195 indexed citations breakdown →

Cheung, Dorothy, Alice Fong, Han Ting Ding, et al.. (2021). A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. Pulmonary Pharmacology & Therapeutics. 69. 102051–102051. 5 indexed citations

Staton, Tracy, Kun Peng, Ryan Owen, et al.. (2019). A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers. BMC Pulmonary Medicine. 19(1). 5–5. 27 indexed citations

Wynn, Daniel, Michael D. Kaufman, Xavier Montalbán, et al.. (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. The Lancet Neurology. 9(4). 381–390. 234 indexed citations

Weiss, Rick, Alice Fong, & Mary J. Kretsch. (2003). Adapting ProNutra to interactively track food weights from an electronic scale using ProNESSy. Journal of Food Composition and Analysis. 16(3). 305–311. 7 indexed citations

Kretsch, Mary J., Alice Fong, & Michael W. Green. (1999). Behavioral and Body Size Correlates of Energy Intake Underreporting by Obese and Normal-weight Women. Journal of the American Dietetic Association. 99(3). 300–306. 135 indexed citations

10.

Dixon, Zisca, Betty J. Burri, Andrew J. Clifford, et al.. (1994). Effects of a carotene-deficient diet on measures of oxidative susceptibility and superoxide dismutase activity in adult women. Free Radical Biology and Medicine. 17(6). 537–544. 48 indexed citations

11.

Burri, B, Zisca Dixon, Alice Fong, et al.. (1993). Possible Association of Skin Lesions with a Low‐Carotene Diet in Premenopausal Women. Annals of the New York Academy of Sciences. 691(1). 279–280. 3 indexed citations

12.

Kretsch, Mary J. & Alice Fong. (1993). Validity and reproducibility of a new computerized dietary assessment method: effects of gender and educational level. Nutrition Research. 13(2). 133–146. 7 indexed citations

13.

Fong, Alice & Mary J. Kretsch. (1990). Nutrition Evaluation Scale System reduces time and labor in recording quantitative dietary intake. Journal of the American Dietetic Association. 90(5). 664–670. 13 indexed citations

14.

Salel, Antone F., Alice Fong, Robert Zelis, et al.. (1977). Accuracy of Numerical Coronary Profile. New England Journal of Medicine. 296(25). 1447–1450. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact